A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Clinical trial NCT05788328 · TERMINATED
Trial details
- NCT number
- NCT05788328
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2023-09-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.